TRUSELTIQ is indicated for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma harboring an FGFR2 fusion or rearrangement as detected by an FDA-approved test. This indication received accelerated approval based on overall response rate and duration of response.
ONGENTYS® is indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing "off" episodes.
EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
Neovascular (Wet) Age-Related Macular Degeneration (nAMD).
Diabetic Macular Edema (DME).
Macular Edema Following Retinal Vein Occlusion (RVO).
DATROWAY is indicated for adult patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer (IHC 0, IHC 1+, or IHC 2+/ISH-) who have received prior endocrine-based therapy and chemotherapy in the metastatic or unresectable setting.
- How to Use Datopotamab deruxtecan (Datroway) Datopotamab deruxtecan (Datroway) is a Trop-2-targeted antibody-drug conjugate (ADC) indicated for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Oct 20, 2025, 11:46 GMT+08:00
- How to Purchase Datopotamab deruxtecan (Datroway) Datopotamab deruxtecan (Datroway) is a novel Trop-2-targeted antibody-drug conjugate (ADC) co-developed by Daiichi Sankyo Co., Ltd. and AstraZeneca. It is used for the treatment of patients with HR-positive/HER2-negative metastatic breast cancer.
Oct 20, 2025, 11:40 GMT+08:00
TRUSELTIQ is indicated for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma harboring an FGFR2 fusion or rearrangement as detected by an FDA-approved test. This indication received accelerated approval based on overall response rate and duration of response.
ONGENTYS® is indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing "off" episodes.
EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
Neovascular (Wet) Age-Related Macular Degeneration (nAMD).
Diabetic Macular Edema (DME).
Macular Edema Following Retinal Vein Occlusion (RVO).
DATROWAY is indicated for adult patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer (IHC 0, IHC 1+, or IHC 2+/ISH-) who have received prior endocrine-based therapy and chemotherapy in the metastatic or unresectable setting.
VAFSEO is indicated specifically for the treatment of anemia due to chronic kidney disease in adult patients receiving dialysis for a minimum of three months.
- How to Use Vadadustat (Vafseo) Vadadustat (Vafseo) is a hypoxia-inducible factor prolyl hydroxylase (HIFPH) inhibitor, indicated for the treatment of anemia associated with chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months.
501
2025-10-27 10:41:39 - Indications for Vadadustat (Vafseo) Vadadustat (Vafseo) is a hypoxia-inducible factor prolyl hydroxylase (HIFPH) inhibitor, used for the treatment of anemia caused by chronic kidney disease (CKD). 501
2025-10-27 10:36:23
- How to Purchase Vadadustat (Vafseo) Vadadustat (Vafseo) is an oral medication used to treat anemia in dialysis patients with chronic kidney disease (CKD), and must be used strictly as directed by a doctor. 501
2025-10-27 10:32:22
- What Are the Side Effects of Avacopan (Tavneos) 501
2025-10-27 10:27:22
- Avacopan (Tavneos) Medication Precautions Avacopan (Tavneos) is a complement 5a receptor (C5aR) antagonist, used as adjunctive therapy for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]) in adults. 502
2025-10-27 10:23:28
- How to Use Avacopan (Tavneos) Avacopan (Tavneos) is a complement 5a receptor (C5aR) antagonist. It is indicated for the treatment of severe active antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]) in adults, when used in combination with standard therapy including glucocorticoids. 501
2025-10-27 10:18:40
- Indications for Avacopan (Tavneos) Avacopan (Tavneos) is a complement 5a receptor (C5aR) antagonist, indicated for the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. 501
2025-10-27 10:14:53
- How to Purchase Avacopan (Tavneos) Avacopan (Tavneos) is a prescription medication used for the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, and must be used strictly as directed by a doctor. 501
2025-10-27 10:09:52
- What Are the Side Effects of Ocrelizumab (Ocrevus) Ocrelizumab (Ocrevus) is a CD20-directed cytolytic antibody used for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) in adults. As a prescription medication, patients must fully understand its safety profile, side effects, and medication precautions. 501
2025-10-27 10:05:27
- Ocrelizumab (Ocrevus) Medication Precautions Ocrelizumab (Ocrevus) is a B-cell depleting antibody targeting CD20, used for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). 502
2025-10-27 09:59:44
